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Abstract  
 
Context and Objective 
Diagnoses and prognoses vary widely across sub-populations of people referred to 
specialist palliative care services; variations also exist in the way these services are 
configured. These variations create substantial heterogeneity in palliative care 
populations enrolled in research studies which, in turn, limits the generalizability of 
study results. This paper reports on the refinement of a checklist of patient/research 
participant and service/research site descriptors; the checklist can be completed for 
any palliative care research study.  Its purposes are to: (1) facilitate the design and 
reporting of rigorous palliative care research, and thereby, (2) aid clinicians in 
appropriately applying research evidence in clinical practice.  
Methods 
A previously published framework (five domains; 13 core sub-domains and 25 non-
core sub-domains) was used to code all research articles (n=189) published over a 
12-month period in the three leading palliative care journals internationally.   
 
Results 
In descending order, the most frequently reported sub-domains were: patient age, 
patient gender and patient diagnosis; model of service delivery and patient 
performance status.  Data in certain sub-domains, such as time from referral to 
death, socio-economic indices and ethnicity, were rarely reported; none of the 
included studies reported whole-of-service or whole-of-population data.  With a total 
of 2,457 core sub-domains that could have been reported (189x13), the included 
studies provided data on 30% (746/2457). 
A simplified list of sub-domains is proposed. Different domains are now identified for 
different study populations in palliative care.  
 
Conclusion 
Checklists such as CONSORT focus mainly on internal validity. The proposed 
checklist adds a checklist specific to the content of palliative care, focusing on 
external validity and the study population. 
 
Key words: study characteristics; reporting guidelines; publishing/standards; quality 
controls; checklists; applicability; generalisability 
 
Running Title: Reporting palliative care trials  
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Introduction  
 
A central task of evidence-based practice is to apply research-generated evidence to 
a patient.[1,2] A central responsibility of researchers, therefore, is to describe the 
generalizability of their research in a way that helps clinicians determine whether, 
and under what circumstances, the findings can be applied to their patients. 
 
Generalizability of a research study’s findings (also termed external validity) defines 
whether or not the findings will hold for all settings beyond that of the study itself.  
Applicability refers to whether or not the results will hold if applied in a particular 
setting. Generalizability is therefore a property of the study, whereas applicability is 
determined by the way in which a clinician uses its results.  In disciplines where 
research populations or the services from which patients are recruited differ widely, 
generalizability may be limited. Palliative care is one such discipline; two palliative 
care services, even in the same health system, can vary widely in their patient 
populations and in their models of service provision. These divergences can create 
very different sub-populations of study participants, even in rigorously designed and 
executed randomised controlled trials, [3,4] and can limit the generalizability of 
reported evidence.[5]  
 
Palliative care is not unique in struggling to report key elements of study design, so 
as to facilitate the application of research findings in practice. In oncology, a recent 
review of randomized, controlled trials of best supportive care interventions found 
that only 11% of such studies published from 2005 to 2008 reported all data 
elements essential to translation of oncology clinical trial data into clinical practice.[6]  
These elements included drug name, dose, route, cycle length, patient 
monitoring parameters, and dosing adjustments for toxicity. Reporting is even less 
rigorous for trials where patients are randomized to either cancer treatment or “best 
supportive care.”[7,8]  
 
Lack of standardized reporting of study design elements can give rise to situations in 
which data derived from the study of one sub-population are used erroneously to 
inform decisions about a different sub-population. In a meta-analysis of 141 trials, 
Dhruva and Redberg found that participants in cardiovascular studies used by the 
Centers for Medicare and Medicaid Services (CMS) for coverage determinations 
differed substantially from the Medicare population to which those coverage 
decisions would apply.[9] Another study of publications in high-impact general 
medical journals found that exclusion criteria defining the populations of randomized 
controlled trials are often not clearly reported or justified, impairing the applicability of 
the results more broadly.[10] Such differences between the study population and a 
population in which results are applied will likely be more pronounced in palliative 
care due to the heterogeneity of its sub-populations and settings.  
 
Method- or design-specific checklists have been developed to explore the internal 
validity of studies. Examples include: CONSORT (Consolidated Standards of 
Reporting Trials) for randomized clinical trials; [11] STROBE (STrengthening the 
Reporting of OBservational Studies in Epidemiology), which pertains to case-control, 
cohort, and cross-sectional studies; [12] AGREE (Appraisal of Guidelines for 
Research and Evaluation), for assessing the quality of observational studies; [13] 
QUORUM (Quality of Reporting of Meta-Analyses);[14]  MOOSE (Meta-Analysis of 
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Observational Studies in Epidemiology); [15] and STARD (Standards for Reporting 
of Diagnostic Accuracy) for diagnostic studies.[16]  
 
To complement the checklists above, given the variations in its populations and 
service models, palliative care research needs a discipline-specific checklist to 
evaluate external validity. This research group previously proposed a supportive and 
palliative care discipline-specific checklist; [5] the checklist comprises a small 
number of easily documented and understood measures, selected to reflect key 
variation between service delivery models and the populations referred to those 
clinical services.  By assessing applicability based on service and patient population 
descriptors, use of this checklist should help in describing and comparing supportive 
and palliative care studies in the future, and should allow more rapid and appropriate 
uptake of new evidence into practice.   
 
The aim of this paper is to: (1) quantify the reporting of study populations and health 
services in the supportive and palliative care-specific literature; and (2) refine the 
descriptors in the checklist based on these data.  
 
 
Methods 
 
A literature search  was conducted using a previously validated Ovid Medline filter 
for palliative care. All articles indexed in the Journal of Pain and Symptom 
Management, Palliative Medicine and Journal of Palliative Medicine were included; 
these three leading palliative care scientific journals were chosen because they have 
the highest annual clinical trial publication rates in the discipline.[17,18]   
 
Journals were searched for 2007 to accommodate any time lag in electronic 
bibliographic indexing.  Inclusion criteria were; published articles reporting all 
empirically-based studies, including controlled trials, cohort studies, cross-sectional 
studies and qualitative studies.  A letter was eligible for inclusion if it reported new 
results. Articles were excluded if they were: other letters to the editor, editorials, 
commentaries, comments, fast facts, patient hand-outs, case reviews, case 
discussions, descriptive studies, consensus statements and systematic reviews. 
 
Each search comprised the palliative care filter (Ovid Medline syntax) limited to the 
journal and the year 2007.[18] Searches were conducted on November 12 and 13, 
2008.  Retrieved articles were downloaded into an Endnote Library (Thomson 
Reuters Endnote X1 for Windows. New York, USA. 2007). Citations and abstracts 
were placed into a Microsoft Excel spreadsheet. (Office Windows 97. Microsoft 
Corporation. Seattle, USA. 1997). The order of these entries was randomized to 
ensure that papers from each journal were not reviewed consecutively.   
 
Eligibility of identified papers was confirmed through abstract review. All papers were 
coded by one investigator (AG) using the framework. [5]  One in ten papers was 
coded independently by a second investigator (DC).  Any discrepancies were settled 
by consensus.   
 
The framework comprises five domains divided into 38 sub-domains.  Sub-domains 
were categorised as core (essential for generalisability; n=13) and non-core (may aid 
 5 
generalisability by supporting a better understanding of the population/setting in 
which the study was conducted; n=25).  
 
Data are reported by: number of fields available compared to number of fields into 
which data could be coded; rates of reporting core and non-core data items; most 
frequently and least frequently coded data items; and whether papers were 
published in their country of origin.  
 
Results 
 
The search identified 409 citations: of these, 189 papers (47%) were included (Table 
1). The proportion of identified papers included for each journal was: Journal of Pain 
and Symptom Management, 47% (51/113); Palliative Medicine, 58% (66/115); and 
Journal of Palliative Medicine, 40% (72/181).  
 
In the patients and caregivers domain, articles provided data only for people 
participating in the study; no article provided data for people referred to the service, 
nor for the total population of people with life-limiting illnesses from whom the service 
population was drawn.  Hence all data subsequently reported herein refer only to 
study participants.  
 
There were a total of 7,182 fields (189x38) into which data could be coded for the 
population and services in the studies. Data were available for only 1129 of these 
fields (15.7%). For 13 core items across 189 papers (189x13=2,457 fields), this 
percentage rose to 30.4% (746/2,457; Table 2). 
 
The percentage of possible fields that could have a response coded for each core 
and non-core sub-domain was tabulated. Articles were 3.5 times more likely to 
provide data for core sub-domains than for non-core sub-domains.  Only 11 papers 
failed to report any core data items; none of these reported studies of patients. 
 
Three domains (patient and caregiver factors; research factors; and service factors) 
accounted for the 10 most frequently reported sub-domains. All sub-domains were 
able to be coded from sub-sets of papers. In descending order, the most frequently 
reported sub-domains were: patient age, patient gender and patient diagnosis; 
model of service delivery; and patient performance status. (Table 3)  Rarely reported 
sub-domains included socio-economic indices, ethnicity, and time from referral to 
death.  
 
The pattern of data provision in the most and least frequently reported sub-domains 
was examined in relation to whether the checklist [5] labelled them “core” or ”non-
core.”  Only one non-core item (primary data source) appeared in the 10 sub-
domains that were most frequently reported.  No core items appeared in the 10 least 
frequently reported sub-domains. The poorest performing core sub-domain was in 
the domain, research factors: “primary outcome measure validated for use in 
palliative care populations.”   
 
In reviewing the research reported in the palliative care literature, it also became 
apparent that more emphasis should be placed on the participant population. 
Participant populations included patients, caregivers, health professionals, healthy 
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volunteers and the community more broadly. Each of these groups warrants a 
tailored version of the checklist. A proposed set of the core domains relating to 
different study populations was also developed. (Table 4)  
 
 
In response to these findings, the core sub-domains were simplified. (Table 5) The 
only sub-domain that deals with internal validity (Has the primary outcome measure 
been validated in a palliative care population?) was retained.  
 
 
Discussion 
 
In a representative cross-section of the palliative and supportive care literature, 
patterns of reporting factors relevant to generalizability were examined. Results 
suggest that it is feasible to report standard study descriptors which can aid with 
evaluation of generalizability in supportive and palliative care, but that reporting 
these factors is incomplete.  
 
Results of the literature search showed significant under-reporting of information that 
is necessary in order for clinicians and health planners to assess the applicability of 
palliative care study findings to their patients or services. No paper covered all core 
sub-domains: in the best case, nine out of 13 were included. Reporting of patient 
factors was better than that of other domains, but even basic patient demographic 
factors such as participants’ ages and genders were not reported universally. Given 
wide local differences in the people referred to, and the structure of, palliative care 
services, the poor reporting of basic descriptive factors can be expected to impede 
the application of newly found knowledge in this field. [4]  
 
Representing an intersection between oncology and palliative care practice, best 
supportive care studies can be viewed as a subset of palliative care research. Best 
supportive care trials should include a coherent description of the care offered 
including assessments undertaken, their schedule and the supports offered.  Ad hoc 
provision of supportive care, without meticulous documentation of what that care 
actually entails, is likely to introduce systematic bias into the interpretation of trial 
results; there is potential for inflation of the apparent benefit of the oncological 
intervention.[8]  The checklist proposed in this paper may help in the design and 
reporting of oncology trials where best supportive care is used as a comparator. 
 
The proposed model bears a structural resemblance to the Center to Advance 
Palliative Care (CAPC) Consensus Recommendations, Operational Features for 
Hospital Palliative Care Programs, which was developed to define specific features 
necessary for program sustainability and growth and to help guide hospitals as they 
start new or strengthen existing palliative care programs.[19] The CAPC framework 
divides 12 operational domains into ”must have” and “should have” 
recommendations, similar to the “core” and “non-core” items in this checklist. The 
operational factors in the CAPC recommendations overlap with some of the items in 
this framework’s service factors domain.  These independently developed 
frameworks can both contribute to the better application of evidence into practice 
and policy. 
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Ideally, to aid readers in interpreting study results and evaluating study 
generalizability, each journal article reporting new palliative care research would 
provide a checklist of the core sub-domains relevant to the study population. Routine 
use of this checklist might also: facilitate systematic comparison between those 
people with advanced disease who are and who are not referred to specialised 
palliative care services; build a better understanding of when findings from one 
population (e.g., palliative cancer care) can or cannot be extrapolated to another 
population (e.g., palliative care in end-stage respiratory failure); encourage more 
rigorous study design, which in turn might increase the clinical applicability of studies 
and expedite synthesis of data into systematic reviews and meta-analyses. 
                                                                                                                                                                                                                                                                                                                                                                                                                                        
Limitations of this study 
 
The development of a framework for generalizability/applicability of best supportive 
and palliative care is evolving work. The model was refined based on results of the 
current study.  Similarly, CONSORT and other reporting frameworks have been 
works in progress over many years with the models evolving as new data are 
analysed. [20] 
 
 
The dataset for this study did not include systematic reviews.  It is likely that 
systematic reviews need to reflect the designs of studies they include, and hence an 
aggregated field such as service or health system descriptors may be difficult to 
report. If studies are reported using the suggested checklist, this approach may 
simplify the task of authors of future systematic reviews, allowing them to more 
easily synthesise and present the myriad data which they aggregate.  
 
 
Applying this checklist 
 
Using the checklist in designing and reporting study results – researchers 
1.   Identify the study question. 
2.   Choose a reporting framework for that methodology. (see Introduction, 
paragraph 5) 
3.   Identify the participant population. (Table 4) 
4.   Ensure that the core sub-domains (Table 5) for that patient population are 
reported in the Results section of the paper.  
 
Using the checklist in reading study results – clinicians and policy-makers  
1.   Read the Introduction of the research publication, and frame the study question 
in your own words. 
2.   Identify the best methodology to answer the question. Have the researchers 
used this methodology? Have they reported their methodology against a standard 
reporting framework? (e.g., CONSORT; see Introduction, paragraph 5) 
3.   Identify the population of participants in the study and hence the core sub-
domains that need to be reported. (Table 5) 
4.   Look for each of the core sub-domains in the Methods and Results section of the 
paper. 
5.   Define the same core sub-domains for your own clinical practice.  
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6.   Compare the characteristics of the study’s core sub-domains with those of the 
service in which you work. If there are major differences in any of the reported 
parameters between the study and your practice, consider how best to adapt the 
research findings, or decide that they cannot be applied in your practice because the 
differences are too significant.  
 
Future research 
 
The data presented cannot answer the question of whether this framework will result 
in a timelier uptake of new and emerging evidence into practice.   
 
Further study would be required to; 
 1) quantify the impact of poor study reporting on applying research findings in 
palliative care i.e. define the current evidence/practice gap; 
 2) do a feasibility/acceptability study of use of the checklist (to determine whether, in 
its current state, people would use it);  
3) assess its validity;  
4)  do a rigorous study on whether the use of this checklist helps in transfer of 
knowledge 
 
Future work – implications for policy and practice 
 
This checklist has two audiences, both of whom need basic appraisal skills to 
optimise its use – researchers generating new knowledge, and end-users (clinicians 
and policy makers) seeking to apply that new knowledge. This checklist provides a 
pragmatic tool that can aid interpretation of studies; it may be especially useful to the 
large number of practitioners whose training pre-dates the routine teaching of critical 
appraisal of the medical literature. Its routine use could help provide structure to 
study parameters, allow readers to more rapidly evaluate new knowledge, and 
thereby facilitate the appropriate application of research evidence in clinical practice. 
 
 
Disclosures:  All authors declare that they have no competing interests 
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Table 1: Included and excluded papers in the study The three international 
palliative care journals with the highest number of palliative care research 
studies 2007. 
 
  Journals   
  
Palliative 
Medicine 
Journal of 
Pain and 
Symptom 
Management 
Journal 
of 
Palliative 
Medicine 
Sub-
total 
Total 
Papers 
initially 
identified 
 
115 113 181 
 
409 
Reason 
papers 
excluded 
Duplicate 
from search 
strategy 
10 2 3 15 
 
Letter to the 
editor 
23 11 11 45 
Editorials, 
commentaries 
5 7 28 40 
Systematic 
reviews 
4 3 2 9 
Descriptive 
papers 
7 33 50 90 
Chart audit  0 2 0 2 
Fast facts, 
patient 
information 
sheets 
0 0 12 12 
Consensus 
statements 
0 4 3 7 
 Sub-total 
papers 
excluded 
49 62 109 220 
Papers 
included 
in final 
analysis 
 
66 51 72 189 
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Table 2:  Reporting of generalizability data items in original research in the 
three top ranked palliative care journals in 2007 
 
Core / 
non-
core 
data 
items 
Domains Potential 
number 
of fields 
captured 
Mean 
number of 
responses 
by article 
for the 
domain 
(SD) 
Median 
(range) 
Percentage 
of possible 
fields with 
response 
 ALL CORE 13 3.96 (2.01) 4 (0-9) 30.4 
Core  Patient and 
caregiver 
characteristics* 
8 3.85 (1.51) 4 (0-8) 48.1 
Professional 
issues 
1 0.12(0.32) 0 (0-1) 11.5 
Best supportive 
and palliative 
care service 
descriptors 
2 0.43(0.52) 0 (0-2) 21.5 
Health and 
social service 
descriptors** 
1 0.15 (0.36) 0 (0-1) 15.2 
Characteristics 
of the research 
1 0.05 (0.21) 0 (0-1) 4.7 
 
Non-
core  
Patient and 
caregiver 
characteristics* 
9 0.15 (0.36) 0 (0-1) 8.4 
Professional 
issues 
3 0.13 (0.42) 0 (0-3) 4.3 
Best supportive 
and palliative 
care service 
descriptors 
8 0.09 (0.39) 0 (0-3) 1.1 
Health and 
social service 
descriptors** 
2 0.05 (0.21) 0 (0-1) 2.4 
Characteristics 
of the research 
3 1.12 (0.57) 1 (0-3) 37.2 
 ALL NON-
CORE 
25 2.05 (1.43) 2 (0-7) 25.1 
*Using the denominator of 108 studies that directly studied patients. 
* *Excludes 94 studies published in the country of origin where such a description is 
arguably superfluous. (n=97) 
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Table 3: The performance of all 13 core data items in original research in the 
three top ranked palliative care journals in 2007 
Domain Sub-domain Classification 
examples 
Percentage 
of studies 
reporting 
these data 
Patient 
and 
caregiver 
Patient – 
demographic 
Age  91.7* 
Gender  88.9* 
Socio-economic indices  32.4* 
Ethnicity  25.9* 
Patient – 
clinical 
Life-limiting illness  73.1* 
Performance status  39.8* 
Time from referral until 
death 
 21.3* 
Caregiver Percentage of people 
with no identifiable 
caregiver 
 11.1* 
Professional Recognised specialty in 
the country where the 
study was done 
 7.4 
Best supportive and 
palliative care service 
issues 
Model of service delivery  Inpatient care, 
community 
care, 
consultative 
care, all of 
these 
41.7 
Basis for referral  Diagnosis, 
prognosis, 
needs-based 
care 
0.9 
Health and social policy Funding mechanisms for 
health care 
User pays, 
universal 
insurance, 
combination 
14.1** 
Research Outcome measures used 
in the study validated in 
the palliative care 
population 
 6.5* 
*Using the denominator of 108 studies that directly studied patients 
* *Excludes 94 studies published in the country of origin where such a description is 
arguably superfluous. (n=97) 
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Table 4: Delineation of fields that is pivotal to applying findings from different 
types of research in best supportive care and hospice research to the local 
environment. This accounts for the intent of the study and the intent of the 
potential application. 
 Domain 
Individual 
participant’s 
demographics* 
Caregiver* Service 
Clinical 
population 
referred 
Descriptors Funding  
S
tu
d
y
 t
y
p
e
 
Healthy volunteer X     
Efficacy 
randomised 
controlled trial 
(RCT) 
X  X   
Other clinical 
intervention trials 
including 
effectiveness 
RCTs 
 
X 
  
X 
 
X 
 
X 
Health services 
research 
(including 
intervention trials) 
 
X 
 
X 
 
X 
 
X 
 
X 
Cohort studies X +/- X X X 
Qualitative X  X +/- +/- 
 
Best supportive 
care as a 
comparator arm 
X X X X X 
* Should include a comparison between potential referrals to the service, those 
referred to the service and, as outlined in this table, those included in the study. 
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Table 5: Revised core checklist to improve the ability of clinicians and service planners to apply best supportive care or 
hospice research to their setting. 
G
e
n
e
ra
liz
a
b
ili
ty
  
- 
e
x
te
rn
a
l 
v
a
lid
it
y
 /
 i
n
te
rn
a
l 
v
a
lid
it
y
 
Domain Sub-domain Measure Population... 
reported in 
this study 
in my service 
Individual participant’s 
demographics 
Age Mean (standard deviation SD)   
Gender Percentage   
Socio-economic indices A nationally accepted index   
Ethnicity Country-specific percentage 
highlighting groups with known 
poorer access and poorer 
outcomes 
  
Caregiver# Caregiver availability Percentage of people with life 
limiting illnesses without an 
identified caregiver 
  
 
 
Service  
Clinical  
population 
referred 
Life-limiting illness Cancer / non-cancer   
Performance status AKPS* or ECOG**   
Time from referral until death Mean (SD), median (range)   
Descriptors Setting of study Inpatient, community, 
outpatient, combination 
  
Basis for referral  Prognosis +/- diagnosis +/- 
needs 
  
Health and social policy Health care funding mechanisms Universal coverage, user pays 
etc 
  
Research Primary outcome measure in study Outcome measures validated in 
palliative care populations 
 
Yes / No 
# Only applicable in studies of caregivers or in health service delivery trials 
*Australian Modified Karnofsky Performance Status [21]  
** Eastern Cooperative Oncology Group functional status [22] 
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